How bacteria resist antibiotics through their protective outer layer
The interplay between cell envelope protein homeostasis and antibiotic resistance in Gram-negative bacteria
This study is looking at how certain proteins in the outer layer of Gram-negative bacteria help them resist antibiotics, which could lead to new ways to fight infections for people dealing with antibiotic-resistant bacteria.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas at Austin NIH-funded |
| Lab location | 1 site (Austin, United States) |
| Project ID | NIH-10974028 on NIH RePORTER |
What this research studies
This research investigates how the outer layer of Gram-negative bacteria, which acts as a barrier against antibiotics, contributes to antibiotic resistance. The study focuses on the proteins within this layer that help bacteria survive antibiotic treatments. By examining the interactions between these resistance proteins and the systems that maintain protein stability, the research aims to uncover new insights into bacterial survival mechanisms. The approach includes laboratory experiments using various bacterial strains to understand the role of specific proteins in resistance.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant Gram-negative bacteria, such as Acinetobacter baumannii.
Not a fit: Patients with infections caused by Gram-positive bacteria or those not affected by antibiotic resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for overcoming antibiotic resistance in bacterial infections.
How similar studies have performed: Previous research has shown promising results in understanding bacterial resistance mechanisms, indicating that this approach could yield valuable insights.
Where this research is happening
Austin, United States
- University of Texas at Austin — Austin, United States (Active)
Researchers
- Principal investigator: Mavridou, Despoina — University of Texas at Austin
- Study coordinator: Mavridou, Despoina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.